Squizzato Alessandro, Ageno Walter, Finazzi Sergio, Mera Valentina, Romualdi Erica, Bossi Anna, Venco Achille
Department of Clinical Medicine, University of Insubria, Varese, Italy.
Blood Coagul Fibrinolysis. 2006 Jun;17(4):303-6. doi: 10.1097/01.mbc.0000224850.57872.d0.
Recent evidence indicates a possible role of D-dimer in the early diagnosis of ischemic stroke subtypes. Whether D-dimer can also predict the long-term outcome following ischemic stroke is controversial. To define the prognostic role of D-dimer, patients hospitalized after an acute ischemic cerebrovascular event underwent D-dimer measurement (Liatest D-D; normal level < 0.50 microg/ml) on admission and were followed up for recurrent cerebrovascular events, occurrence of other cardiovascular events, and mortality. We enrolled 96 patients (mean age 74.9 years, 42 men). Mean follow-up was 61.5 months; 47 (48.5%) patients died, 23 (48.9%) because of a vascular event. There was no difference in mean D-dimer levels between dead patients and survivors (1.68 and 1.63 microg/ml, P = NS), but the mortality risk was higher with D-dimer of at least 0.50 microg/ml (odds ratio, 5.32; 95% confidence interval, 1.79-15.84). After adjustment for age and stroke subtype, the odds ratio was not significant. Mean D-dimer was similar between patients with and without a new vascular event (1.43 and 1.68 microg/ml, P = NS), and D-dimer of at least 0.50 microg/ml was not predictive of an increased risk of subsequent events. D-dimer levels measured in the acute phase after an acute cerebrovascular event probably do not predict the long-term clinical outcome.
近期证据表明,D-二聚体在缺血性卒中亚型的早期诊断中可能发挥作用。D-二聚体是否也能预测缺血性卒中后的长期预后仍存在争议。为明确D-二聚体的预后作用,对急性缺血性脑血管事件后住院的患者入院时进行了D-二聚体检测(Liatest D-D;正常水平<0.50微克/毫升),并随访复发性脑血管事件、其他心血管事件的发生情况及死亡率。我们纳入了96例患者(平均年龄74.9岁,男性42例)。平均随访61.5个月;47例(48.5%)患者死亡,23例(48.9%)死于血管事件。死亡患者与存活患者的平均D-二聚体水平无差异(分别为1.68和1.63微克/毫升,P=无显著性差异),但D-二聚体水平至少为0.50微克/毫升时死亡风险更高(比值比,5.32;95%置信区间,1.79 - 15.84)。在调整年龄和卒中亚型后,比值比无显著性意义。有新发血管事件和无新发血管事件的患者平均D-二聚体水平相似(分别为1.43和1.68微克/毫升,P=无显著性差异),且D-二聚体水平至少为0.50微克/毫升不能预测随后事件风险增加。急性脑血管事件急性期检测的D-二聚体水平可能无法预测长期临床预后。